📖

LRRK2 Inhibitor Therapy

active

wiki page Created: 2026-04-02T20:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-therapeutics-lrrk2-inhibitor-therap

Related Entities

therapeutics-lrrk2-inhibitor-therapy

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

📊 Evidence Profile

Evidence Balance

+0%

Certainty

100%

Debates

Incoming

243

Outgoing

289

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Linked Artifacts (356)

mentions🔬Analysis question not specified100%

mentions🔬Multiple NDDs converge on autophagy-lysosome dysfunction. Ar100%

mentions🔬TDP-43 undergoes liquid-liquid phase separation that becomes100%

mentions🔬APOE4 differs from APOE3 by C112R causing domain interaction100%

mentions🔬SPMs (resolvins, protectins, maresins) from omega-3s may pro100%

mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%

mentions🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 70%

mentions🧫Epigenetic Dysregulation Validation in Parkinson's Dise70%

mentions🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki70%

mentions🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#70%

mentions🧫Combination Therapy Sequencing in Parkinson's Disease70%

mentions🧫GLP-1 Agonist Responder Prediction Study — Precision Medicin70%

mentions🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design70%

mentions🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio70%

mentions🧫AAV-LRRK2 IND-Enabling Study Design70%

mentions🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera70%

mentions🧫AAV Serotype Comparison for LRRK2 Knockdown in PD70%

mentions🧫Computational Modeling of Alpha-Synuclein Propagation in PD70%

mentions🧫MLCS Quantification in Parkinson's Disease70%

mentions🧫Prodromal Parkinson's Disease Biomarker Development — E70%

mentions🧫Macroautophagy Dysfunction in PD - Experiment Design70%

mentions🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation70%

mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy70%

mentions🧫Experiment: Multi-Ethnic PD GWAS70%

mentions🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown70%

mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides70%

mentions🧪Circadian-Synchronized LRP1 Pathway Activation70%

mentions🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%

mentions🧫Ferroptosis Validation in Parkinson's Disease70%

mentions🧪APOE Isoform Conversion Therapy70%

mentions🧫Regulated Necrosis Validation Study in Parkinson's Dise70%

mentions🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne70%

mentions🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D70%

related🧫Experiment: Multi-Ethnic PD GWAS63%

related🧪APOE Isoform Conversion Therapy63%

see_also📖LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for APOE55%

see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and55%

mentions🧪Complement-Mediated Synaptic Pruning Dysregulation50%

mentions🧪Purinergic P2Y12 Inverse Agonist Therapy50%

mentions🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)50%

mentions🧪APOE Isoform Expression Across Glial Subtypes50%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%

mentions🧪Hypocretin-Neurogenesis Coupling Therapy50%

mentions🧪Complement C1q Subtype Switching50%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%

mentions🧪Competitive APOE4 Domain Stabilization Peptides50%

mentions🧪HCN1-Mediated Resonance Frequency Stabilization Therapy50%

mentions🧪Glial Glycocalyx Remodeling Therapy50%

mentions🧪TET2-Mediated Demethylation Rejuvenation Therapy50%

mentions🧪Arginine Methylation Enhancement Therapy50%

mentions🧪SIRT6-NAD+ Axis Enhancement Therapy50%

mentions🧪R-Loop Resolution Enhancement Therapy50%

mentions🧪Selective Acid Sphingomyelinase Modulation Therapy50%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%

mentions🧪Orexin-Microglia Modulation Therapy50%

mentions🧪Microglial Purinergic Reprogramming50%

mentions🧪Near-infrared light therapy stimulates COX4-dependent mitoch50%

mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th50%

mentions🧪Lysosomal Calcium Channel Modulation Therapy50%

mentions🧪Complement C1QA Spatial Gradient in Cortical Layers50%

mentions🧪Complement C1q Mimetic Decoy Therapy50%

mentions🧪Gamma entrainment therapy to restore hippocampal-cortical sy50%

mentions🧪CYP46A1 Overexpression Gene Therapy50%

mentions🧪PARP1 Inhibition Therapy50%

see_also📖LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy for 50%

mentions🧪Ganglioside Rebalancing Therapy50%

see_also📖Cholinergic System Dysfunction in Neurodegeneration45%

see_also📖Disease Progression & Staging in Neurodegeneration45%

see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration45%

see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 45%

see_also📖Sleep Dysfunction in Neurodegeneration45%

see_also📖Noradrenergic Signaling Pathway in Neurodegeneration45%

see_also📖Japan Neurodegeneration Epidemiology45%

see_also📖acetylcholine-signaling-neurodegeneration45%

see_also📖IL-6 (Interleukin-6) in Neurodegeneration45%

see_also📖Metal Homeostasis in Neurodegeneration45%

see_also📖Tertiary Lymphoid Organs in Neurodegeneration45%

see_also📖Lipid Dysregulation in Neurodegeneration45%

see_also📖Molecular Chaperones in Neurodegeneration45%

see_also📖Progesterone Signaling Pathway in Neurodegeneration45%

see_also📖FA2H-Associated Neurodegeneration Pathway45%

see_also📖Down Syndrome Neurodegeneration Pathway45%

see_also📖synaptic-vesicle-cycling-neurodegeneration45%

see_also📖DALY Methodology — Neurodegeneration45%

see_also📖mTOR Signaling in Neurodegeneration45%

see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 45%

see_also📖RAN Translation in Neurodegeneration45%

see_also📖Vagus Nerve Pathway in Neurodegeneration45%

see_also📖remternetug-anti-amyloid-alzheimers45%

see_also📖Autosis Pathway in Neurodegeneration45%

see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration45%

see_also📖Mitochondrial Fusion in Neurodegeneration45%

see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St45%

see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread45%

see_also📖Ribosome Dysfunction in Neurodegeneration45%

see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen45%

see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration45%

see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio45%

see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration45%

see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration45%

see_also📖Galectin-3 Mechanism in Neurodegeneration45%

see_also📖Nitric Oxide Signaling in Neurodegeneration45%

see_also📖Neuropil Threads in Neurodegeneration45%

see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration45%

see_also📖Adipose-Derived Mesenchymal Stem Cell Therapy for Early Alzh45%

see_also📖Paranodal Dysfunction in Neurodegeneration45%

see_also📖Integrated Stress Response in Neurodegeneration45%

see_also📖India Neurodegeneration Epidemiology45%

see_also📖SUMOylation in Neurodegeneration45%

see_also📖APOE4 (Apolipoprotein E4)45%

see_also📖Neurovascular Unit Dysfunction in Neurodegeneration45%

see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration45%

see_also📖Neuroimaging Biomarkers for Neurodegeneration45%

see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat45%

see_also📖PKR Pathway in Neurodegeneration45%

see_also📖mitochondrial-dysfunction-neurodegeneration-comparison45%

see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration45%

see_also📖Computational Disease Models for Neurodegeneration45%

see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)45%

see_also📖Prion Diseases in Neurodegeneration45%

see_also📖Metabolomic Biomarkers in Neurodegeneration45%

see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)45%

see_also📖NRF2 Signaling Pathway in Neurodegeneration45%

see_also📖Sex Differences in Neurodegeneration45%

see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain45%

see_also📖CaMKII Signaling Pathway in Neurodegeneration45%

see_also📖Advanced Glycation End Products in Neurodegeneration45%

see_also📖PPAR Signaling Pathway in Neurodegeneration45%

see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration45%

see_also📖Neural Circuits in Neurodegeneration45%

see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati45%

see_also📖Protein Aggregation Comparison in Neurodegeneration45%

see_also📖Economic Burden — Neurodegeneration45%

see_also📖IGF-1 Signaling Pathway in Neurodegeneration45%

see_also📖Sigma-1 Receptor Signaling in Neurodegeneration45%

see_also📖Cortical Involvement and Neurodegeneration in Progressive Su45%

see_also📖Prion-Like Spread in Neurodegeneration45%

see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration45%

see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl45%

see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration45%

see_also📖IL-1 Signaling Pathway in Neurodegeneration45%

see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration45%

see_also📖Prion Protein Metabolism in Neurodegeneration45%

see_also📖Kidney-Brain Neurodegeneration Axis45%

see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration45%

see_also📖Copper Homeostasis in Neurodegeneration45%

see_also📖GDF15/GDF11 Signaling in Neurodegeneration45%

see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio45%

see_also📖Exosomal Biomarkers in Neurodegeneration45%

see_also📖Sleep Disorders in Neurodegeneration45%

see_also📖Gangliosides in Neurodegeneration45%

see_also📖Retinal Degeneration Pathway in Neurodegeneration45%

see_also📖Neuronal Hyperexcitability in Neurodegeneration45%

see_also📖UPenn Observational Research Repository (NCT04715399)45%

see_also📖Familial vs Sporadic Neurodegeneration Comparison45%

see_also📖Axon Guidance Pathways in Neurodegeneration45%

see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration45%

see_also📖Endothelin Signaling Pathway in Neurodegeneration45%

see_also📖Neuropeptide Y Signaling in Neurodegeneration45%

see_also📖T-Cell Dysfunction in Neurodegeneration45%

see_also📖Microglial Priming Pathway in Neurodegeneration45%

see_also📖Homocysteine Neurotoxicity and Neurodegeneration45%

see_also📖Purinergic Signaling in Neurodegeneration45%

see_also📖Protein Aggregation Seeds in Neurodegeneration45%

see_also📖Cognitive Reserve and Resilience in Neurodegeneration45%

see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)45%

see_also📖Serotonergic Dysfunction in Neurodegeneration45%

see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration45%

see_also📖Exosomal miR-155 in Neurodegeneration45%

see_also📖European Neurodegeneration Epidemiology45%

see_also📖Ghrelin Signaling Pathway in Neurodegeneration45%

see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime45%

see_also📖Digital Phenotyping in Neurodegeneration45%

see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration45%

see_also📖Antibody Therapy in Neurodegeneration45%

see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration45%

see_also📖epigenetics-neurodegeneration45%

see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a45%

see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr45%

see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration45%

see_also📖COVID-19 Neurodegeneration Mechanism45%

see_also📖Convergent Pathways in Neurodegeneration45%

see_also📖RNA-Targeted Therapies in Neurodegeneration45%

see_also📖Endosomal Sorting Defects in Neurodegeneration45%

see_also📖A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month45%

see_also📖Prognostic Biomarkers in Neurodegeneration45%

see_also📖Manganese-Related Neurodegeneration (Manganism)45%

see_also📖Therapeutic Targets in Neurodegeneration45%

see_also📖RNA Splicing in Neurodegeneration45%

see_also📖Cell-Free DNA Biomarkers in Neurodegeneration45%

see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 45%

see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration45%

see_also📖PLA2G6-Associated Neurodegeneration (PLAN)45%

see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N45%

see_also📖Endocannabinoid System in Neurodegeneration45%

see_also📖Global Neurodegeneration Epidemiology45%

see_also📖P-Body (Processing Body) Pathway in Neurodegeneration45%

see_also📖Orexin Signaling in Neurodegeneration45%

see_also📖Neural Circuit Disruption in Neurodegeneration45%

see_also📖HMGB1 Signaling in Neurodegeneration45%

see_also📖Paraptosis in Neurodegeneration45%

see_also📖nct0550878945%

see_also📖Parthanatos in Neurodegeneration45%

see_also📖Lipid Metabolism Dysregulation in Neurodegeneration45%

see_also📖Senescent Cell Clearance in Neurodegeneration45%

see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 45%

see_also📖NF-kB Signaling Pathway in Neurodegeneration45%

see_also📖US Neurodegeneration Epidemiology45%

see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)45%

see_also📖Glycosylation in Neurodegeneration45%

see_also📖Diffusion MRI (DTI) in Neurodegeneration45%

see_also📖Amylin Signaling in Neurodegeneration45%

see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration45%

see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener45%

see_also📖Metal Homeostasis Dysregulation in Neurodegeneration45%

see_also📖S100 Protein Signaling Pathway in Neurodegeneration45%

see_also📖Liquid Biopsy in Neurodegeneration45%

see_also📖MicroRNA Dysfunction in Neurodegeneration45%

see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration45%

see_also📖ALA-enriched Nutrition for APOE4 Carriers with MCI (NCT0739245%

see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration45%

see_also📖Pericyte Loss in Neurodegeneration45%

see_also📖interleukin-6-signaling-neurodegeneration45%

see_also📖Hippocampal Neurogenesis in Neurodegeneration45%

see_also📖Histone Modification Pathways in Neurodegeneration45%

see_also📖Dystrophic Neurites in Neurodegeneration45%

see_also📖China Neurodegeneration Epidemiology45%

see_also📖Neurotensin Signaling in Neurodegeneration45%

see_also📖Short Chain Fatty Acids in Neurodegeneration45%

see_also📖Synaptic Biomarkers in Neurodegeneration45%

see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration45%

see_also📖GDNF Signaling Pathway in Neurodegeneration45%

see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration45%

see_also📖mTOR Signaling Pathway in Neurodegeneration45%

see_also📖A Phase 2 Double-Blind, Randomized, Placebo-Controlled Trial45%

see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration45%

see_also📖R-Loop Stress in Neurodegeneration45%

see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration45%

see_also📖Potential Impact Measures — Neurodegeneration45%

mentions🧫Metal Ion Homeostasis Dysregulation in Alzheimer's Dise44%

mentions🔬What are the mechanisms underlying senolytic therapy for age40%

mentions🔬Senescent cell clearance as neurodegeneration therapy40%

mentions🔬What are the mechanisms underlying tdp-43 phase separation t40%

mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%

related🧪PARP1 Inhibition Therapy40%

mentions🔬What are the mechanisms underlying blood-brain barrier trans40%

related🧪Ganglioside Rebalancing Therapy40%

related🧪Ganglioside Rebalancing Therapy35%

related🧪PARP1 Inhibition Therapy35%

related🧪APOE Isoform Conversion Therapy35%

LRRK2 Inhibitor Therapy

💬 Discussion